A. Muhlethaler-Mottet

Discipline

Linguistique (1) Economies et finances (1)

Type de document

Articles (15) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Neuroblastoma (16) Cells (14) Tumors (11) Expression (10) modèle (7) Mice (7) Example (7) Children (7) Tumors (7) gène (6) Cell lines (6) tumeur (5) survie (5) Treatment (5) Control (5) Apoptosis (5) Survival (5) Poor (5) Human beings (5) Addition (5) enfance (5) spectacle (4) maladie (4) ligne (4) Methods (4) Tissues (4) Patients (4) Lymphomas (4) Cancer (4) Methods (4)

Documents écrit par A. Muhlethaler-Mottet (16) | parle de A. Muhlethaler-Mottet (0)

TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth.
M.V. Sepporta et al. (12 janv. 2022)
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
A. Mühlethaler-Mottet et al. (2022)
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
A. Bellini et al. (20 oct. 2021)
The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation.
K. Abid et al. (5 janv. 2021)
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
L. Vivancos Stalin et al. (2019)
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
M. Flahaut et al. (2016)
The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
A. Mühlethaler-Mottet et al.
Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
G. Montavon et al. (2014)
Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma.
J. Liberman et al. (2012)
The ALK-F1174L activating mutation is tumorigenic in MONC-1 neural crest stem cells in an orthotopic murine model of neuroblastoma
A. Muhlethaler-Mottet et al. (2012)
Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
A Coulon et al.
Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.
A Mühlethaler-Mottet et al.
Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
G Raguénez et al.
Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells
A. Mühlethaler-Mottet et al. (2008)
The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
R. Meier et al. (2007)
Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
A. Mühlethaler-Mottet et al. (2006)